Biointron is excited to announce our upcoming collaborative webinar with the Antibody Society, scheduled for June 26th, 2025. This webinar will feature our speaker, Dr. Gang Liu, Associate Director of Biointron. Dr. Liu will delve into the captivating topic of "AbDrop Speeds: Accelerating Your Antibody Discovery with Single B Solution," providing attendees with a rich and informative exploration of the latest trends and advancements in antibody discovery technologies.
Lei Shi, PhD, Senior Vice President of Biointron, discusses: "Simplified and Humanized: Empowering Human Antibody Discovery with AbDrop™ Solution" during the Antibody Engineering & Therapeutics US 2024 conference in San Diego.
Biointron has established an industry-leading 2-week antibody production service, supported by a powerful high-throughput expression platform.
This topic explores the revolutionary potential of the genome-edited mouse HUGO-Ab, where endogenous VH and VL genes are replaced by fully human VH and VL genes in situ, enabling the generation of fully human antibody molecules.
Biointron's SVP of R&D, Lei Shi, PhD, discussed the processes of accelerating early discovery through HTP and high-speed antibody production during the Antibody Engineering & Therapeutics US 2023 conference in San Diego. Below is a summary of the talk.
Talk Title: Innovative Multiple Tech & Platforms Empower Antibody DiscoverySpeaker: Dr.Long Xu, Director, R&D Strategy at BiointronBiointron is excited to announce our upcoming collaborative webinar with the Antibody Society, scheduled for September 26th, 2023. This webinar will featur